VVT Medical specializes in the research, development, manufacturing and commercialization of minimally invasive, non-thermal non-tumescent- NT-NT solutions for the treatment of varicose veins.
VVT Medical’s advanced, proprietary solutions combine best practices in vein treatment with a powerful, patented delivery system to provide a simpler, more effective approach to treatment. Its flagship ScleroSafe platform enables physicians to perform quick, office-based procedures without the need for tumescent anesthesia or costly capital equipment. VVT Medical’s solutions can be performed in a range of outpatient settings including vein clinics, day care clinics, angio suites, catheterization laboratories and hospitals.
ScleroSafe with V-Block is especially designed to simply, safely and effectively treat severely dilated and challenging Great Saphenous Vein (GSV) conditions, including GSV valve incompetence and Reflux.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics